MELISSA BLACK: Open Payments
NPI 1659077238 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $335
Food & beverage: $246Education: $89
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 2 | $111 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Lilly USA, LLC | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: XYWAV, KEYTRUDA, Fabhalta, INSPIRE, Venclexta, JAKAFI, VERZENIO, Lenvima.
Industry payments across ID — which companies pay providers there.
